Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Exploring Research on Early Warning Indicators of Protein in Patients With Mild Cognitive Impairment and Alzheimer's Disease
Authors not listed
Guangzhou University of Traditional Chinese Medicine · 2021
Abstract
This study intends to adopt standardized and rigorous cross-sectional research, collect biological specimens (including blood, feces, urine, saliva and tongue coating) from eligible subjects, and use liquid chromatography/mass spectrometry (LC-MS/MS) technology to explore early warning indicators of protein in patients with mild cognitive impairment and Alzheimer's disease
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2021). Exploring Research on Early Warning Indicators of Protein in Patients With Mild Cognitive Impairment and Alzheimer's Disease. <em>Guangzhou University of Traditional Chinese Medicine</em>. https://clinicaltrials.gov/study/NCT04804618
Vancouver
Anonymous. Exploring Research on Early Warning Indicators of Protein in Patients With Mild Cognitive Impairment and Alzheimer's Disease. Guangzhou University of Traditional Chinese Medicine. 2021.
BibTeX
@misc{anon2021Explor,
title = {Exploring Research on Early Warning Indicators of Protein in Patients With Mild Cognitive Impairment and Alzheimer's Disease},
author = {Anonymous},
journal = {Guangzhou University of Traditional Chinese Medicine},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ascentys Ltd 2023
Open access · US-GOV
Feasibility Study for the Use of Computer Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Assistance Publique - Hôpitaux de Paris 2007
Open access · US-GOV
A Multicenter Study to Assess Differences Between Circulating Levels of IGF-I and IGFBP-3 in Patients With Sporadic Late-onset Alzheimer's Disease and Control Elderly Subjects.
GlaxoSmithKline 2010
Open access · US-GOV
Modulation of Beta-amyloid Levels in CSF and Plasma by GSK933776 in Patients With Mild Alzheimer's Disease or Mild Cognitive Impairment
Biomed Industries, Inc. 2018
Open access · US-GOV
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Efficacy of NA-831 in Alzheimer Patients With Mild Cognitive Impairment
Neurobiology of Disease 2014
Preprint · OA
Early detection of Alzheimer's disease using PiB and FDG PET
Florida Atlantic University 2007
Open access · US-GOV